ABSI vs. ABCL

Last updated Jun 3, 2026

ABSI (Absci Corporation) and ABCL (AbCellera Biologics Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 3 years, ABSI returned 50.04%/yr vs -3.35%/yr for ABCL. At a 0.48 correlation, their price movements are largely independent.

Performance

ABSI vs. ABCL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Absci Corporation (ABSI) and AbCellera Biologics Inc. (ABCL). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

The year-to-date returns for both stocks are quite close, with ABSI having a 81.95% return and ABCL slightly lower at 79.24%.

ABSI

• 1D: -2.61%
• 1M: 29.07%
• YTD: 81.95%
• 6M: 109.57%
• 1Y: 132.60%
• 3Y*: 50.04%
• 5Y*: —
• 10Y*: —

ABCL

• 1D: -5.11%
• 1M: 38.37%
• YTD: 79.24%
• 6M: 77.17%
• 1Y: 186.45%
• 3Y*: -3.35%
• 5Y*: -24.85%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ABSI vs. ABCL - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
ABSI Absci Corporation	81.95%	33.21%	-37.62%	100.00%	-74.39%	-62.02%
ABCL AbCellera Biologics Inc.	79.24%	16.72%	-48.69%	-43.63%	-29.16%	-10.79%

Correlation

The correlation between ABSI and ABCL is 0.56, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.56
Correlation (3Y) Calculated over the trailing 3-year period	0.53
Correlation (All Time) Calculated using the full available price history since Jul 23, 2021	0.48

The correlation between ABSI and ABCL has been stable across timeframes, ranging from 0.48 to 0.56 - a consistent structural relationship.

Fundamentals

Market Cap ABSI : $971.31M ABCL : $1.86B
EPS ABSI : -$0.82 ABCL : -$0.48
PS Ratio ABSI : 563.05 ABCL : 23.20
PB Ratio ABSI : 5.65 ABCL : 1.98
Total Revenue (TTM) ABSI : $1.62M ABCL : $79.21M
Gross Profit (TTM) ABSI : -$21.67M ABCL : $70.89M
EBITDA (TTM) ABSI : -$115.23M ABCL : -$166.07M

Return for Risk

ABSI vs. ABCL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ABSI

ABSI Risk / Return Rank: 77
ABSI Sharpe Ratio Rank: 80
ABSI Sortino Ratio Rank: 79
ABSI Omega Ratio Rank: 76
ABSI Calmar Ratio Rank: 79
ABSI Martin Ratio Rank: 74

ABCL

ABCL Risk / Return Rank: 85
ABCL Sharpe Ratio Rank: 90
ABCL Sortino Ratio Rank: 87
ABCL Omega Ratio Rank: 83
ABCL Calmar Ratio Rank: 86
ABCL Martin Ratio Rank: 80

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ABSI vs. ABCL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Absci Corporation (ABSI) and AbCellera Biologics Inc. (ABCL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ABSI	ABCL	Difference
Sharpe ratio Return per unit of total volatility	1.43	2.37	-0.93
Sortino ratio Return per unit of downside risk	2.28	2.96	-0.68
Omega ratio Gain probability vs. loss probability	1.27	1.34	-0.07
Calmar ratio Return relative to maximum drawdown	2.59	3.70	-1.12
Martin ratio Return relative to average drawdown	4.76	6.78	-2.02
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ABSI vs. ABCL - Sharpe Ratio Comparison

The current ABSI Sharpe Ratio is 1.43, which is lower than the ABCL Sharpe Ratio of 2.37. The chart below compares the historical Sharpe Ratios of ABSI and ABCL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	ABSI	ABCL	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.43	2.37	-0.93
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.38	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.23	-0.49	+0.25

Drawdowns

ABSI vs. ABCL - Drawdown Comparison

The maximum ABSI drawdown since its inception was -96.20%, roughly equal to the maximum ABCL drawdown of -96.72%. Use the drawdown chart below to compare losses from any high point for ABSI and ABCL.

Drawdown Indicators

	ABSI	ABCL	Difference
Max Drawdown Largest peak-to-trough decline	-96.20%	-96.72%	+0.52%
Max Drawdown (1Y) Largest decline over 1 year	-54.00%	-54.94%	+0.94%
Max Drawdown (3Y) Largest decline over 3 years	-66.06%	-75.72%	+9.66%
Max Drawdown (5Y) Largest decline over 5 years	—	-92.64%	—
Current Drawdown Current decline from peak	-79.04%	-89.59%	+10.55%
Average Drawdown Average peak-to-trough decline	-84.81%	-83.59%	-1.22%
Ulcer Index Depth and duration of drawdowns from previous peaks	29.31%	30.00%	-0.69%

Volatility

ABSI vs. ABCL - Volatility Comparison

Absci Corporation (ABSI) has a higher volatility of 30.14% compared to AbCellera Biologics Inc. (ABCL) at 27.48%. This indicates that ABSI's price experiences larger fluctuations and is considered to be riskier than ABCL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ABSI	ABCL	Difference
Volatility (1M) Calculated over the trailing 1-month period	30.14%	27.48%	+2.66%
Volatility (6M) Calculated over the trailing 6-month period	65.23%	52.39%	+12.84%
Volatility (1Y) Calculated over the trailing 1-year period	93.03%	79.41%	+13.62%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	96.52%	66.45%	+30.07%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	96.52%	70.04%	+26.48%

Dividends

ABSI vs. ABCL - Dividend Comparison

Neither ABSI nor ABCL has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ABSI and ABCL in my portfolio?

ABSI and ABCL have a correlation of 0.56, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ABSI or ABCL?

ABSI has higher volatility (30.14%) compared to ABCL (27.48%). In terms of maximum drawdown, ABSI dropped -96.20% vs ABCL's -96.72%.

Which has better risk-adjusted returns?

ABCL currently has the higher Sharpe Ratio (2.37 vs 1.43), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.